Proteomic biomarkers and diagnostic tools in ovarian cancer: understanding their clinical value and limitations

INIS

• values 100%
• cancer 100%
• biological markers 100%
• diagnostic techniques 100%
• ovaries 100%
• applications 30%
• sensitivity 20%
• specificity 20%
• reviews 10%
• validation 10%
• patients 10%
• utilities 10%
• symptoms 10%
• management 10%
• detection 10%
• monitoring 10%
• proteins 10%
• quality of life 10%
• screening 10%
• mortality 10%
• lethals 10%
• mass spectrometry 10%
• raman spectroscopy 10%
• immunoassay 10%
• pathological changes 10%

Medicine and Dentistry

• Biological Marker 100%
• Ovarian Cancer 100%
• Proteomics 100%
• Proteome 33%
• Sensitivity and Specificity 22%
• Biological Phenomena and Functions Concerning the Entire Organism 11%
• Raman Spectrometry 11%
• Recurrence Risk 11%
• Mortality Rate 11%
• Mass Spectrum 11%
• Patient Monitoring 11%
• Screening Test 11%
• Cellular Mechanism 11%
• Cancer Diagnostics 11%
• Immunoassay 11%
• Cancer Biomarkers 11%
• Quality of Life 11%
• Female Genital Tract Cancer 11%

Biochemistry, Genetics and Molecular Biology

• Proteome 100%
• Proteomics 100%
• Biomarker Discovery 33%
• Screening Test 33%
• Mass Spectrometry 33%
• Mortality Rate 33%
• Biological Phenomena and Functions Concerning the Entire Organism 33%
• Immunoassay 33%
• Peptidome 33%
• Biomarker Validation 33%